桃李麪包(603866.SH):實控人之一吳志剛質押2085萬股
格隆匯 2 月 7日丨桃李麪包(603866.SH)公佈,公司於2021年2月7日收到公司控股股東及實際控制人之一吳志剛的通知,吳志剛將其持有的公司2085萬股無限售條件流通股質押給山東省國際信託股份有限公司,相關手續已辦理完成。
吳志剛未來半年到期的質押股份數量800萬股,佔其所持股份比例11.21%、佔公司總股本比例的1.18%,對應融資餘額1億元;未來一年內(不含半年內)到期的質押股份數量1250萬股,佔其所持股份比例17.52%、佔公司總股本比例的1.84%,對應融資餘額2.4億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.